GenScript Biotech and T-MAXIMUM collaborate on cGMP sgRNA
Under the agreement, T-MAXIMUM Biotech will get several CRISPR reagents from GenScript to aid in the development of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Aug 23
Under the agreement, T-MAXIMUM Biotech will get several CRISPR reagents from GenScript to aid in the development of…
10 Aug 23
At week 12, both Phase 3 studies' primary endpoints of absolute change from baseline in the weekly UAS7…
10 Aug 23
The proposed acquisition will enhance the ongoing partnership between Decibel and Regeneron and the partnership aims to expedite…
10 Aug 23
The capital garnered from the Series C financing will be channelled towards further advancement of ADARx's ongoing clinical…
10 Aug 23
The acquisition expands Lilly's immunology portfolio to include DICE's novel oral therapeutic candidates, including oral IL-17 inhibitors currently…
10 Aug 23
VANFLYTA is not indicated as maintenance monotherapy following allogeneic hematopoietic stem cell transplantation (HSCT); improvement in overall survival…
09 Aug 23
Neopharm will be appointed as Amarin’s sole and exclusive distributor to import, register, distribute, and commercialise Vazkepa in…
09 Aug 23
Under the investment, SK bioscience will acquire a 7% stake or 6.5 million shares of Novavax’s common stock…
09 Aug 23
The company is planning to cut operations at its Canton, Massachusetts, facility and Rockville, Maryland factory and lay…
09 Aug 23
The cardiovascular outcomes trial evaluated subcutaneous once-weekly semaglutide 2.4mg against placebo as an adjunct to the standard of…